Albuterol Sulfate Inhalant
Product Images NDC 69097-142

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate (NDC 69097-142). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

111686cc F94f 4de7 88df Ee3d1cfe34e9 01

FDA Label Image

111686cc F94f 4de7 88df Ee3d1cfe34e9 02

This text presents data from a 12-week clinical trial that compares the percent change in FEV (forced expiratory volume) after treatment with Albuterol sulfate inhalation aerosol and CFC 1112 Albuterol, both taken four times a day, and a placebo (HFA-134a), also taken four times a day. The study involved 193 participants who used the Albuterol sulfate inhalation aerosol, 186 participants who used CFC 1112 Albuterol, and 186 participants who used the placebo.*

FDA Label Image

111686cc F94f 4de7 88df Ee3d1cfe34e9 03

The text is a call to action for viewers to learn more about a product known as "ciplaalbuterolhfa" with instructions to visit a website, scan a code or make a call to access a video demonstration or more information.*

FDA Label Image

111686cc F94f 4de7 88df Ee3d1cfe34e9 04

FDA Label Image

111686cc F94f 4de7 88df Ee3d1cfe34e9 05

FDA Label Image

111686cc F94f 4de7 88df Ee3d1cfe34e9 06

The text appears to be a diagram or image with labels, rather than a description. It is not possible to provide a useful description with this text.*

FDA Label Image

111686cc F94f 4de7 88df Ee3d1cfe34e9 07

FDA Label Image

111686cc F94f 4de7 88df Ee3d1cfe34e9 08

FDA Label Image

111686cc F94f 4de7 88df Ee3d1cfe34e9 09

FDA Label Image

111686cc F94f 4de7 88df Ee3d1cfe34e9 10

FDA Label Image

111686cc F94f 4de7 88df Ee3d1cfe34e9 11

This is a prescription-only inhalation aerosol with a dose indicator provided. It contains Albuterol sulfate equivalent to 90 mcg albuterol per actuation along with propellant, ethanol, and oleic acid. The inhaler recommends not exceeding the prescribed dose. The package also includes a package insert for further information. It should be stored at a controlled room temperature between 20°C to 25°C. The inhaler must be shaken well before use and should be stored with the mouthpiece pointing down. The manufacturer of this aerosol is Cipla L, which is located in Indore SEZ, Pithampur, India. The product is packaged by CiplaUSA, Inc. and contains a net quantity of 6.7g.*

FDA Label Image

111686cc F94f 4de7 88df Ee3d1cfe34e9 12

This text provides information about Albuterol Sulfate Inhalation Aerosol, including its active ingredient and dose indicator, and the fact that it contains no chlorofluorocarbons (CFCs). The text also includes warnings and instructions for use, such as avoiding spraying it in the eyes and keeping it away from heat or open flame. The text contains contact information for more information and a video demonstration on how to use it.*

FDA Label Image

111686cc F94f 4de7 88df Ee3d1cfe34e9 13

This is a description of a prescription drug, Albuterol Sulfate Inhalation Aerosol, with a dose indicator, manufactured by Cipla. Each actuation of the enclosed actuator delivers a microcrystalline suspension of Albuterol Sulfate in HFA-1342, ethanol, and olfac. There are 200 metered inhalations in the package. The warning advises not to exceed the dose prescribed by a physician and to seek medical attention immediately if breathing difficulty persists. The drug should be stored at a temperature between 20°C-25°C. Shake well before use. The manufacturer of this drug is Cipla LSA, located in Warten, NJ.*

FDA Label Image

111686cc F94f 4de7 88df Ee3d1cfe34e9 14

This is a description for Albuterol Sulfate Inhalation Aerosol. It is used for oral inhalation to relieve symptoms like wheezing and shortness of breath caused by asthma and other respiratory problems. It is important to read the warnings and instructions carefully. The dosage should not be increased without consulting with a physician, and the inhaler should be stored at room temperature. The label includes information on dosage, contents, manufacturer, and storage. There is also an unvarnished area for batch overprinting.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.